-
Nippon India Pharma Fund - Growth
Equity healthcare
Overview ( as on 11/07/25 )
NAV
₹515.74
Last change
₹0.71 +0.0%
Fund Size (AUM)
8352.16 Cr
Performance
21.91% (5Y)
Fund Details
Nippon India Pharma Fund - Growth
as of 11/07/25
AUM
8352.16 Cr
Expense Ratio
1.8 %
Benchmark
BSE Healthcare TR INR
ISIN
INF204K01968
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma Fund - Growth | 11.18% | 24.54% | 21.91% |
| BSE Healthcare TR INR | 19.26% | 27.0% | 22.17% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
12.23% |
Divi's Laboratories Ltd |
8.5% |
Lupin Ltd |
6.07% |
Cipla Ltd |
5.62% |
Apollo Hospitals Enterprise Ltd |
5.48% |
Dr Reddy's Laboratories Ltd |
5.18% |
Medplus Health Services Ltd |
3.83% |
GlaxoSmithKline Pharmaceuticals Ltd |
3.63% |
Narayana Hrudayalaya Ltd |
3.55% |
Vijaya Diagnostic Centre Ltd |
3.32% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
24.45% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
23.99% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
23.99% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
21.72% (5Y)
-
-
UTI Healthcare Reg Gr
Equity healthcare-
Returns
-
22.02% (5Y)
-
-
UTI Healthcare Reg IDCW-P
Equity healthcare-
Returns
-
22.02% (5Y)
-
